Answer
Sacubitril + valsartan enhances natriuretic peptide effects through sacubitril’s active metabolite LBQ657, which inhibits neprilysin and reduces peptide degradation, enhancing signalling through guanylyl cyclase-coupled receptors that increases cyclic guanosine monophosphate (cGMP).
Sources for this answer
- Entresto film-coated tabletsNovartis Pharmaceuticals UK Ltd · emc · SmPC §5.1 Pharmacodynamic properties · Version 15Document updated
Sources checked